The Food and Drugs administration (FDA) on Saturday said it has seized about 12 lakh tablets of Tramadol (habit forming drug) worth Rs 85 lakh from an Amritsar-based pharmaceutical firm.
During an inspection by an FDA team, it was found that the firm had stocked a huge quantity of Tramadol tablets without seeking a permission for the same, an official statement quoted Punjab health minister Balbir Singh Sidhu as saying.
A notice under Rule 66(1) of the Drugs and Cosmetics Rules, 1945 has been issued for taking action against the firm and further investigation is underway, Sidhu said.
He said to keep a tab on the illegal sale and purchase of habit forming drugs, the FDA was conducting regular checking of wholesale and retail sale drugs' licencees.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app